|Articles|May 1, 2013
- Pharmaceutical Executive-05-01-2013
- Volume 0
- Issue 0
PE, May 2013 Cover Image
S
Advertisement
Cover
Articles in this issue
almost 13 years ago
Tracking Trial Cost Drivers: The Impact of Comparator Drugs and Co-Therapiesalmost 13 years ago
Is That VBP on the Horizon, or a Mirage?almost 13 years ago
Country Report: Austriaalmost 13 years ago
The Friendly Persuasion — An Interview with Fred Hassanalmost 13 years ago
Whistling Past the Graveyardalmost 13 years ago
The Patent Black Labelalmost 13 years ago
It's Time For a Code of Ethics in Patient Educationalmost 13 years ago
The Health Information Advantagealmost 13 years ago
Generic Drug Gains and GrumblesNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Pharmaceutical Executive Daily: Shah Capital's Plan to Vote Against Novavax Board Nominees
2
Medical Supply Chains at Risk Over Escalating Conflicts in Iran: Report
3
Q&A: Supply Chain Fallout From Iran War, Tariff Uncertainty
4
Novavax Stock Increases as Shah Capital Plans to Vote Against Board Nominees
5